{"entity":{"type":"insider","cik":"0001986597","url":"/insider/0001986597","json_url":"/insider/0001986597.json","name":"Sarchi Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2023-11-17","last":"2026-06-03","span_basis":"filed_date"},"name_variants":[{"name":"Sarchi Christopher","source":"filing","n_filings":8,"first_seen":"2023-11-17","last_seen":"2026-06-03"}],"transactions":[{"id":5892866,"accession":"0001104659-26-070256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-070256","line_url":"/filing/0001104659-26-070256#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":9.24,"price_display":"9.24","price_state":"stated","total_value":110880.0,"total_display":"110,880.00","shares_owned_after":180962.0,"shares_owned_after_display":"180,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider"},{"id":5835505,"accession":"0001104659-26-064523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-064523","line_url":"/filing/0001104659-26-064523#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8626.0,"shares_display":"8,626","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":43820.08,"total_display":"43,820.08","shares_owned_after":192962.0,"shares_owned_after_display":"192,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":5999470,"accession":"0001104659-26-039967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-039967","line_url":"/filing/0001104659-26-039967#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":52065.0,"total_display":"52,065.00","shares_owned_after":151588.0,"shares_owned_after_display":"151,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider"},{"id":4875864,"accession":"0001104659-25-114124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-114124","line_url":"/filing/0001104659-25-114124#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5208.0,"shares_display":"5,208","price_per_share":9.1,"price_display":"9.10","price_state":"stated","total_value":47392.8,"total_display":"47,392.80","shares_owned_after":123088.0,"shares_owned_after_display":"123,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4111855,"accession":"0001104659-25-052140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-052140","line_url":"/filing/0001104659-25-052140#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3749.0,"shares_display":"3,749","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":30179.45,"total_display":"30,179.45","shares_owned_after":128296.0,"shares_owned_after_display":"128,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":2686173,"accession":"0001104659-24-121187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-121187","line_url":"/filing/0001104659-24-121187#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5207.0,"shares_display":"5,207","price_per_share":10.78,"price_display":"10.78","price_state":"stated","total_value":56131.46,"total_display":"56,131.46","shares_owned_after":87045.0,"shares_owned_after_display":"87,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":2599779,"accession":"0001104659-24-063564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-063564","line_url":"/filing/0001104659-24-063564#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2218.0,"shares_display":"2,218","price_per_share":6.47,"price_display":"6.47","price_state":"stated","total_value":14350.46,"total_display":"14,350.46","shares_owned_after":92252.0,"shares_owned_after_display":"92,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":8430241,"accession":"0001104659-23-119645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-119645","line_url":"/filing/0001104659-23-119645#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001986597","owner_name":"Sarchi Christopher","owner_url":"/insider/0001986597","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5255.0,"shares_display":"5,255","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":57384.6,"total_display":"57,384.60","shares_owned_after":72245.0,"shares_owned_after_display":"72,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Officer (Chief Commercial Officer)","n_filings":8,"first_seen":"2023-11-17","last_seen":"2026-06-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001986597","retrieved_at":"2026-08-21T18:53:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}